Literature DB >> 24786831

Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response.

B C Nair1, S R Krishnan1, G R Sareddy1, M Mann1, B Xu2, M Natarajan1, P Hasty1, D Brann3, R R Tekmal1, R K Vadlamudi1.   

Abstract

Proline-, glutamic acid- and leucine-rich protein-1 (PELP1) is a scaffolding oncogenic protein that functions as a coregulator for a number of nuclear receptors. p53 is an important transcription factor and tumor suppressor that has a critical role in DNA damage response (DDR) including cell cycle arrest, repair or apoptosis. In this study, we found an unexpected role for PELP1 in modulating p53-mediated DDR. PELP1 is phosphorylated at Serine1033 by various DDR kinases like ataxia-telangiectasia mutated, ataxia telangiectasia and Rad3-related or DNAPKc and this phosphorylation of PELP1 is important for p53 coactivation functions. PELP1-depleted p53 (wild-type) breast cancer cells were less sensitive to various genotoxic agents including etoposide, camptothecin or γ-radiation. PELP1 interacts with p53, functions as p53-coactivator and is required for optimal activation of p53 target genes under genomic stress. Overall, these studies established a new role of PELP1 in DDRs and these findings will have future implications in our understanding of PELP1's role in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786831      PMCID: PMC4131173          DOI: 10.1038/cdd.2014.55

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  45 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 3.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

4.  Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.

Authors:  Yali Dou; Thomas A Milne; Alan J Tackett; Edwin R Smith; Aya Fukuda; Joanna Wysocka; C David Allis; Brian T Chait; Jay L Hess; Robert G Roeder
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

5.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.

Authors:  P Giannakakou; G Poy; Z Zhan; T Knutsen; M V Blagosklonny; T Fojo
Journal:  Oncogene       Date:  2000-06-22       Impact factor: 9.867

7.  Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.

Authors:  R K Vadlamudi; R A Wang; A Mazumdar; Y Kim; J Shin; A Sahin; R Kumar
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

Review 8.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

Review 9.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.

Authors:  Sujit S Nair; Sandip K Mishra; Zhibo Yang; Seetharaman Balasenthil; Rakesh Kumar; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

View more
  24 in total

Review 1.  Minireview: Deciphering the Cellular Functions of PELP1.

Authors:  Preethi Ravindranathan; Carol A Lange; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2015-07-09

2.  Cancer: Acidic shield puts a chink in p53's armour.

Authors:  Michelle C Barton
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

3.  Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells.

Authors:  Samaya R Krishnan; Binoj C Nair; Gangadhara R Sareddy; Sudipa Saha Roy; Mohan Natarajan; Takayoshi Suzuki; Yan Peng; Ganesh Raj; Ratna K Vadlamudi
Journal:  Breast Cancer Res Treat       Date:  2015-03-19       Impact factor: 4.872

Review 4.  PELP1: a key mediator of oestrogen signalling and actions in the brain.

Authors:  R Thakkar; G R Sareddy; Q Zhang; R Wang; R K Vadlamudi; D Brann
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

5.  PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

Authors:  Valerie Cortez; Cathy Samayoa; Andrea Zamora; Lizatte Martinez; Rajeshwar R Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2014-11-06       Impact factor: 12.701

Review 6.  PELP1: Structure, biological function and clinical significance.

Authors:  Gangadhara Reddy Sareddy; Ratna K Vadlamudi
Journal:  Gene       Date:  2016-03-18       Impact factor: 3.688

7.  Dose-dependent metabolic alterations in human cells exposed to gamma irradiation.

Authors:  Yong-Kook Kwon; In Jin Ha; Hyun-Whee Bae; Won Gyo Jang; Hyun Jin Yun; So Ra Kim; Eun Kyeong Lee; Chang-Mo Kang; Geum-Sook Hwang
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 8.  P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.

Authors:  T Velletri; N Xie; Y Wang; Y Huang; Q Yang; X Chen; Q Chen; P Shou; Y Gan; G Cao; G Melino; Y Shi
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

Review 9.  Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis.

Authors:  S Nicolai; M Pieraccioli; A Peschiaroli; G Melino; G Raschellà
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

10.  TAp73 transcriptionally represses BNIP3 expression.

Authors:  Varvara Petrova; Mara Mancini; Massimiliano Agostini; Richard A Knight; Margherita Annicchiarico-Petruzzelli; Nikolai A Barlev; Gerry Melino; Ivano Amelio
Journal:  Cell Cycle       Date:  2015-08-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.